On May 28, 2020, Bayer China, a leading company in the Chinese pharmaceutical scene,  revealed plans of co-developing a Clinical Trial Traceability Platform based on the VeChain blockchain called cSecure. This solution monitors user and product data ensuring consistency throughout the trial of clinical drugs thereby improving precision and safety.  VeChain and Bayer China Deal

.

Read more at btcmanager.com

Leave a Reply

Your email address will not be published. Required fields are marked *